PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada (IMRIC), The Hebrew University Hadassah Medical School, Jerusalem, Israel.\', \'Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.\', \'Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.\', \'Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.\', \'Lautenberg Center for General and Tumor Immunology, The Hebrew University Faculty of Medicine, Jerusalem, Israel.\', \'Clinical Virology Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.ppat.1010175
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 34929007
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all